Literature DB >> 6419709

Sex chromosome anomalies, hormones, and aggressivity.

R C Schiavi, A Theilgaard, D R Owen, D White.   

Abstract

This double-blind, controlled study of XYY and XXY men found in a birth cohort of 4,591 tall men born in Copenhagen assessed evidence of delinquent and aggressive behavior and explored the role of hormonal determinants in the behavioral and psychological differences noted among groups. Information from social records, a structured psychological interview, and projective tests did not support the notion that men with sex chromosome anomalies are particularly violent or aggressive. Hormonally, XYY men had significantly higher concentrations of testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) than matched control groups. In contrast, XXY men had higher levels of LH, FSH, and prolactin, but low concentrations of testosterone. There was a significantly positive relation among all subjects as well as XY controls alone between plasma testosterone level and evidence of criminal convictions. A proportionate increase in testosterone levels was noted when subjects were divided into nondelinquents, delinquents without violent convictions, and delinquents with violent convictions. The relation between testosterone level and criminal behavior was not reflected in measures of aggression derived from the psychological interview and projective tests. There was no specific evidence that testosterone is a mediating factor in the criminal behavior of XYY men.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6419709     DOI: 10.1001/archpsyc.1984.01790120097012

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  9 in total

1.  Mosaic double aneuploidy: Down syndrome and XYY.

Authors:  Mayur Parihar; Beena Koshy; Vivi Miriam Srivastava
Journal:  Indian J Hum Genet       Date:  2013-07

Review 2.  Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review.

Authors:  M S Bahrke; C E Yesalis; J E Wright
Journal:  Sports Med       Date:  1990-11       Impact factor: 11.136

3.  Behavioral and social phenotypes in boys with 47,XYY syndrome or 47,XXY Klinefelter syndrome.

Authors:  Judith L Ross; David P Roeltgen; Harvey Kushner; Andrew R Zinn; Allan Reiss; Martha Zeger Bardsley; Elizabeth McCauley; Nicole Tartaglia
Journal:  Pediatrics       Date:  2012-03-12       Impact factor: 7.124

4.  Social function in multiple X and Y chromosome disorders: XXY, XYY, XXYY, XXXY.

Authors:  Jeannie Visootsak; John M Graham
Journal:  Dev Disabil Res Rev       Date:  2009

5.  47,XYY syndrome: clinical phenotype and timing of ascertainment.

Authors:  Martha Zeger Bardsley; Karen Kowal; Carly Levy; Ania Gosek; Natalie Ayari; Nicole Tartaglia; Najiba Lahlou; Breanna Winder; Shannon Grimes; Judith L Ross
Journal:  J Pediatr       Date:  2013-06-27       Impact factor: 4.406

6.  Testicular function in boys with 47,XYY and relationship to phenotype.

Authors:  Shanlee M Davis; Luke Bloy; Timothy P L Roberts; Karen Kowal; Amanda Alston; Aysha Tahsin; Alyssa Truxon; Judith L Ross
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-06-16       Impact factor: 3.908

7.  Disorder of Sexual Development and Congenital Heart Defect in 47XYY: Clinical Disorder or Coincidence?

Authors:  Hanane Latrech; Imane Skikar; Mohammed El Hassan Gharbi; Abdelmjid Chraïbi; Ahmed Gaouzi
Journal:  Case Rep Endocrinol       Date:  2015-06-15

8.  Disorder of Sexual Development Males With XYY in Blood Have Exactly X/XY/XYY Mosaicism in Gonad Tissues.

Authors:  Yongjia Yang; Fang Chen; Zhenqing Luo; Yu Zheng; Jiayong Zheng; Yuyan Fu; Weijian Chen; Haiyan Luo
Journal:  Front Genet       Date:  2021-04-12       Impact factor: 4.599

Review 9.  Neurocognitive outcomes of individuals with a sex chromosome trisomy: XXX, XYY, or XXY: a systematic review.

Authors:  Victoria Leggett; Patricia Jacobs; Kate Nation; Gaia Scerif; Dorothy V M Bishop
Journal:  Dev Med Child Neurol       Date:  2010-01-05       Impact factor: 5.449

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.